NASDAQ: TYRA - Tyra Biosciences, Inc.

Yield per half year: -56.15%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Tyra Biosciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc., биофармацевтическая компания на доклинической стадии, специализируется на разработке методов лечения, направленных на преодоление резистентности к опухолям и улучшение результатов для пациентов с онкологическими заболеваниями. Его ведущим кандидатом в продукт является TYRA-300, селективный ингибитор рецептора фактора роста фибробластов (FGFR) 3 для лечения мышечно-инвазивного рака мочевого пузыря.

more details
Компания также разрабатывает программы, нацеленные на злокачественные опухоли, связанные с FGFR2, ахондроплазию, связанную с FGFR3, киназу REarranged во время трансфекции и злокачественные опухоли, связанные с FGFR4. Tyra Biosciences, Inc. была зарегистрирована в 2018 году, ее штаб-квартира находится в Карлсбаде, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-09-15
ISIN US90240B1061
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.tyra.bio
Цена ао 10.26
Change price per day: -0.485% (10.31)
Change price per week: -8.06% (11.16)
Change price per month: -19.97% (12.82)
Change price per 3 month: -27.18% (14.09)
Change price per half year: -56.15% (23.4)
Change price per year: -37.06% (16.3)
Change price per 3 year: -7.48% (11.09)
Change price per year to date: -29.24% (14.5)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 3.05 5
P/E 21.43 7
EV/EBITDA -7.17 0
Total: 4.38

Efficiency

Title Value Grade
ROA, % -30.61 0
ROE, % -33.85 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0816 10
Total: 7.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 2467.48 10
Yield EPS, % 304.72 10
Total: 8
More

Institutions Volume Share, %
5AM Venture Management, LLC 939 1.79
Vanguard Group Inc 900 1.71
Boxer Capital, LLC 6 12.27
BVF Inc. 5 8.87
Canaan Partners XI LLC 4 8.39
Nextech Invest Ag 4 7.72
FMR, LLC 4 7.57
Tcg Crossover Management, Llc 2 3.79
Fairmount Funds Management LLC 1 2.65
Blackrock Inc. 1 1.99

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Micro-Cap ETF 0.12551 17.09 1.54048
iShares Russell 2000 Growth ETF 0.03642 38.04 0.6026
iShares Morningstar Small Cap Value ETF 0.01068 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.01068 201.65 2.50476
iShares Morningstar Small-Cap ETF 0.00785 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00785 391.25 1.60498
iShares Morningstar Small-Cap Growth ETF 0.0053 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.0053 587.89 0.72598
iShares Russell 3000 ETF 0.00107 24.83 1.43482
0.03150.131.47



Head Job title Payment Year of birth
Dr. Todd Harris Ph.D. Co-Founder, President, CEO, Secretary, Treasurer & Director 903.33k 1979 (46 years)
Mr. Daniel Bensen Co-Founder & COO 630.8k 1976 (49 years)
Dr. Ronald V. Swanson Ph.D. Chief Scientific Officer 536.19k 1964 (61 year)
Dr. Robert L. Hudkins Ph.D. Chief Technology Officer N/A 1956 (69 years)
Dr. Hiroomi Tada M.D., Ph.D. Chief Medical Officer 519.65k 1964 (61 year)
Dr. Piyush R. Patel Ph.D. Chief Development Officer N/A 1966 (59 years)
Mr. Ali D. Fawaz J.D. General Counsel 629.23k
Ms. Sarah Honig Vice President of Corporate Development & Strategy N/A
Mr. Alan Fuhrman Chief Financial Officer N/A 1957 (68 years)
Liz Pagano Senior Vice President of Human Resources

Address: United States, Carlsbad, CA , 2656 State Street - open in Google maps, open in Yandex maps
Website: https://www.tyra.bio